tradingkey.logo
tradingkey.logo
Suchen

Upexi Inc

UPXI
Zur Watchlist hinzufügen
1.450USD
-0.070-4.61%
Handelsschluss 05/15, 16:00ETKurse um 15 Minuten verzögert
101.88MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Upexi Inc Unternehmen

Upexi, Inc. is a solana-focused treasury company. The Company is a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space. The Company’s brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX is a full line of medicinal mushroom products, designed by effect for consumers, which are cultivated, extracted, and produced in the United States. Its products are distributed in the United States of America and internationally through multiple entities and managed through locations in Florida.

Upexi Inc Informationen

BörsenkürzelUPXI
Name des UnternehmensUpexi Inc
IPO-datumJun 24, 2021
CEOMarshall (Allan)
Anzahl der mitarbeiter59
WertpapierartOrdinary Share
GeschäftsjahresendeJun 24
Addresse3030 Rocky Point Drive
StadtTAMPA
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl33607
Telefon17013535425
Websitehttps://upexi.com/
BörsenkürzelUPXI
IPO-datumJun 24, 2021
CEOMarshall (Allan)

Führungskräfte von Upexi Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Allan Marshall ,
Allan Marshall ,
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
3.31M
+6.04%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
685.37K
+14.59%
Mr. Andrew J. Norstrud
Mr. Andrew J. Norstrud
Chief Financial Officer, Director
Chief Financial Officer, Director
589.14K
+40.74%
Mr. Thomas Charles Williams
Mr. Thomas Charles Williams
Independent Director
Independent Director
100.00K
--
Mr. Lawrence H. Dugan
Mr. Lawrence H. Dugan
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Investor Relations
Investor Relations
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Allan Marshall ,
Allan Marshall ,
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
3.31M
+6.04%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
685.37K
+14.59%
Mr. Andrew J. Norstrud
Mr. Andrew J. Norstrud
Chief Financial Officer, Director
Chief Financial Officer, Director
589.14K
+40.74%
Mr. Thomas Charles Williams
Mr. Thomas Charles Williams
Independent Director
Independent Director
100.00K
--
Mr. Lawrence H. Dugan
Mr. Lawrence H. Dugan
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Investor Relations
Investor Relations
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Mon, Apr 6
Währung: USDAktualisiert: Mon, Apr 6
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q1
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Internally manufactured
2.04M
70.03%
Contract manufactured
855.12K
29.40%
Purchased as finished goods
16.63K
0.57%
Nach RegionUSD
Name
Umsatz
Anteil
United States of America
2.86M
98.37%
Other
47.46K
1.63%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Internally manufactured
2.04M
70.03%
Contract manufactured
855.12K
29.40%
Purchased as finished goods
16.63K
0.57%

Aktionärsstatistik

Aktualisiert: Thu, May 14
Aktualisiert: Thu, May 14
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Samara Special Opportunities
6.44%
Vanguard Capital Management, LLC
4.81%
Marshall (Allan)
4.72%
Arrington Capital Investment Management, LLC
3.93%
GSR Growth Investments LP
3.82%
Andere
76.27%
Aktionäre
Aktionäre
Anteil
Samara Special Opportunities
6.44%
Vanguard Capital Management, LLC
4.81%
Marshall (Allan)
4.72%
Arrington Capital Investment Management, LLC
3.93%
GSR Growth Investments LP
3.82%
Andere
76.27%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
16.79%
Corporation
10.78%
Individual Investor
8.43%
Hedge Fund
8.35%
Investment Advisor/Hedge Fund
5.62%
Research Firm
2.91%
Bank and Trust
0.40%
Venture Capital
0.23%
Pension Fund
0.15%
Andere
46.33%

Institutionelle Beteiligung

Aktualisiert: Wed, Apr 1
Aktualisiert: Wed, Apr 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q1
122
23.05M
34.45%
-188.43K
2025Q4
98
14.39M
22.84%
-8.99M
2025Q3
60
18.50M
31.42%
+11.94M
2025Q2
46
10.18M
21.50%
+7.63M
2025Q1
42
311.78K
28.56%
-35.31K
2024Q4
42
307.62K
23.29%
-32.82K
2024Q3
40
303.51K
29.16%
-55.91K
2024Q2
40
319.39K
30.68%
-45.58K
2024Q1
42
328.34K
32.32%
-46.59K
2023Q4
42
319.26K
31.43%
-34.26K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Samara Special Opportunities
4.53M
7.16%
+4.53M
--
Aug 29, 2025
Marshall (Allan)
3.31M
5.24%
+200.00K
+6.42%
Dec 23, 2025
Arrington Capital Investment Management, LLC
2.76M
3.96%
+2.76M
--
Dec 31, 2025
GSR Growth Investments LP
2.69M
4.25%
+380.35K
+16.49%
Sep 30, 2025
MMCAP Asset Management
766.93K
1.21%
-12.17M
-94.07%
Sep 30, 2025
Millennium Management LLC
365.96K
0.58%
-19.30K
-5.01%
Sep 30, 2025
Rudick (Brian Benjamin)
838.60K
1.33%
+400.00K
+91.20%
Jul 16, 2025
Susquehanna International Group, LLP
751.48K
1.19%
+637.36K
+558.48%
Sep 30, 2025
Qube Research & Technologies Ltd
744.44K
1.07%
+744.44K
--
Dec 31, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Datum
Ex-Dividendentag
Art
Verhältnis
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
KeyAI